My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 289

    1.

    Aldose reductase pathway inhibition improved vascular and C-fiber functions, allowing for pressure-induced vasodilation restoration during severe diabetic neuropathy.

    Demiot C, Tartas M, Fromy B, Abraham P, Saumet JL, Sigaudo-Roussel D.

    Diabetes. 2006 May;55(5):1478-83.PMID: 16644708 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Preservation of pressure-induced cutaneous vasodilation by limiting oxidative stress in short-term diabetic mice.

    Demiot C, Fromy B, Saumet JL, Sigaudo-Roussel D.

    Cardiovasc Res. 2006 Jan;69(1):245-52. Epub 2005 Nov 2.PMID: 16266692 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Effect of treating streptozotocin-induced diabetic rats with sorbinil, myo-inositol or aminoguanidine on endoneurial blood flow, motor nerve conduction velocity and vascular function of epineurial arterioles of the sciatic nerve.

    Coppey LJ, Gellett JS, Davidson EP, Dunlap JA, Yorek MA.

    Int J Exp Diabetes Res. 2002;3(1):21-36.PMID: 11900277 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Prevention and reversal of defective axonal transport and motor nerve conduction velocity in rats with experimental diabetes by treatment with the aldose reductase inhibitor Sorbinil.

    Tomlinson DR, Moriarty RJ, Mayer JH.

    Diabetes. 1984 May;33(5):470-6.PMID: 6202576 [PubMed - indexed for MEDLINE]Related articles

    5.

    Continuous inhibition of excessive polyol pathway flux in peripheral nerves by aldose reductase inhibitor fidarestat leads to improvement of diabetic neuropathy.

    Mizuno K, Kato N, Makino M, Suzuki T, Shindo M.

    J Diabetes Complications. 1999 May-Jun;13(3):141-50.PMID: 10509874 [PubMed - indexed for MEDLINE]Related articles

    6.

    Early endothelial dysfunction severely impairs skin blood flow response to local pressure application in streptozotocin-induced diabetic mice.

    Sigaudo-Roussel D, Demiot C, Fromy B, Koïtka A, Lefthériotis G, Abraham P, Saumet JL.

    Diabetes. 2004 Jun;53(6):1564-9.PMID: 15161762 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    The effect of sorbinil, an aldose reductase inhibitor, on aortic function in control and streptozotocin-induced diabetic rats.

    Sellers DJ, Chess-Williams R.

    J Auton Pharmacol. 2000 Feb;20(1):15-22.PMID: 11048957 [PubMed - indexed for MEDLINE]Related articles

    8.

    An aldose reductase inhibitor reverses early diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense.

    Obrosova IG, Van Huysen C, Fathallah L, Cao XC, Greene DA, Stevens MJ.

    FASEB J. 2002 Jan;16(1):123-5. Epub 2001 Nov 14.PMID: 11709499 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    An aldose reductase inhibitor, TAT, reduces ADP-induced platelet hyperaggregation in streptozotocin-induced diabetic rats with neuropathy.

    Hara T, Nakamura J, Koh N, Sakakibara F, Hamada Y, Sasaki H, Naruse K, Nakashima E, Takeuchi N, Inukai S, et al.

    J Lab Clin Med. 1995 Dec;126(6):541-7.PMID: 7490513 [PubMed - indexed for MEDLINE]Related articles

    10.

    Regeneration and repair of myelinated fibers in sural-nerve biopsy specimens from patients with diabetic neuropathy treated with sorbinil.

    Sima AA, Bril V, Nathaniel V, McEwen TA, Brown MB, Lattimer SA, Greene DA.

    N Engl J Med. 1988 Sep 1;319(9):548-55.PMID: 3136331 [PubMed - indexed for MEDLINE]Related articles

    11.

    [Role of aldose reductase inhibitors in the development of peripheral neuropathy in experimental diabetes]

    Kuchmerovskaia TM, Donchenko GV, Klimenko AP, Chichkovskaia GV, Pakirbaeva LV, Kozitskiĭ ZIa, Efimov AS.

    Ukr Biokhim Zh. 1997 May-Jun;69(3):77-82. Russian. PMID: 9505366 [PubMed - indexed for MEDLINE]Related articles

    12.

    Effects of 15-month aldose reductase inhibition with fidarestat on the experimental diabetic neuropathy in rats.

    Kato N, Mizuno K, Makino M, Suzuki T, Yagihashi S.

    Diabetes Res Clin Pract. 2000 Oct;50(2):77-85.PMID: 10960717 [PubMed - indexed for MEDLINE]Related articles

    13.

    Neuropathy in diabetic mice overexpressing human aldose reductase and effects of aldose reductase inhibitor.

    Yagihashi S, Yamagishi SI, Wada Ri R, Baba M, Hohman TC, Yabe-Nishimura C, Kokai Y.

    Brain. 2001 Dec;124(Pt 12):2448-58.PMID: 11701599 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Clinical studies with an aldose reductase inhibitor in the autonomic and somatic neuropathies of diabetes.

    Jaspan JB, Towle VL, Maselli R, Herold K.

    Metabolism. 1986 Apr;35(4 Suppl 1):83-92.PMID: 3083212 [PubMed - indexed for MEDLINE]Related articles

    15.

    Aldose reductase inhibition in the treatment of diabetic neuropathy: where are we in 2004?

    Gabbay KH.

    Curr Diab Rep. 2004 Dec;4(6):405-8. Review.PMID: 15539002 [PubMed - indexed for MEDLINE]Related articles

    16.

    Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy: the 3-year, multicenter, comparative Aldose Reductase Inhibitor-Diabetes Complications Trial.

    Hotta N, Akanuma Y, Kawamori R, Matsuoka K, Oka Y, Shichiri M, Toyota T, Nakashima M, Yoshimura I, Sakamoto N, Shigeta Y.

    Diabetes Care. 2006 Jul;29(7):1538-44.PMID: 16801576 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Endothelial and neural regulation of skin microvascular blood flow in patients with diabetic peripheral neuropathy: effect of treatment with the isoform-specific protein kinase C beta inhibitor, ruboxistaurin.

    Brooks B, Delaney-Robinson C, Molyneaux L, Yue DK.

    J Diabetes Complications. 2008 Mar-Apr;22(2):88-95.PMID: 18280438 [PubMed - indexed for MEDLINE]Related articles

    18.

    The effects of streptozotocin-induced diabetes and aldose reductase inhibition with sorbinil, on left and right atrial function in the rat.

    Sellers DJ, Chess-Williams R.

    J Pharm Pharmacol. 2000 Jun;52(6):687-94.PMID: 10875546 [PubMed - indexed for MEDLINE]Related articles

    19.

    Neurovascular interactions between aldose reductase and angiotensin-converting enzyme inhibition in diabetic rats.

    Cotter MA, Mirrlees DJ, Cameron NE.

    Eur J Pharmacol. 2001 Apr 13;417(3):223-30.PMID: 11334854 [PubMed - indexed for MEDLINE]Related articles

    20.

    Nerve conduction and aldose reductase inhibition during 5 years of diabetes or galactosaemia in dogs.

    Engerman RL, Kern TS, Larson ME.

    Diabetologia. 1994 Feb;37(2):141-4.PMID: 8163047 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity